Semax vs Selank
Semax is mainly studied for focus, memory, mental clarity. while Selank is studied for stress management, mood, cognitive calm. The difference is in the mechanism and the evidence, not in which is "better": it depends on the goal.
| Semax | Selank | |
|---|---|---|
| Category | Cognitive | Cognitive |
| Studied for | Focus, memory, mental clarity. | Stress management, mood, cognitive calm. |
| How it acts | A peptide studied for its relationship with neuroprotection and modulation of factors linked to cognitive function and focus. | A peptide studied for its relationship with anxiety modulation and mood balance, without marked sedation in the literature. |
| Evidence level | Limited human evidence | Limited human evidence |
How they differ
Although sometimes mentioned together, Semax and Selank do not target the same thing. Semax: A peptide studied for its relationship with neuroprotection and modulation of factors linked to cognitive function and focus. Selank: A peptide studied for its relationship with anxiety modulation and mood balance, without marked sedation in the literature.
See full entry: Semax → · See full entry: Selank →
Want to truly understand it, not memorize it?
The course explains each peptide at a university level: how it acts, what outcomes are studied, what it combines with and when to pause. No doses: the protocol is defined by a professional.
See the course → Start with the free test →Frequently asked questions
What is the main difference between Semax and Selank?
Semax targets focus, memory, mental clarity. and Selank targets stress management, mood, cognitive calm. They act through different pathways, so the choice depends on your goal, not on which is "stronger".
Can they be studied together?
Combinations are studied by goal in the literature, but combining is not just adding: it changes the safety profile. What to combine and how is decided with a professional; here we only explain what each is studied for.
Which has more human evidence?
Based on the references we verified, Semax has more human studies of this pair. Each one's evidence level is in the table above, and the references with their PMID are at the end.
Other comparisons
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for Semax vs Selank or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
References
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]human Zh Nevrol Psikhiatr Im S S Korsakova · 2018 · PMID 29798983 →
- Effects of Semax on the Default Mode Network of the Brainhuman Bull Exp Biol Med · 2018 · PMID 30225715 →
- The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysispreclinical BMC Genomics · 2014 · PMID 24661604 →
- Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrainpreclinical J Neurochem · 2006 · PMID 16635254 →
- [Optimization of the treatment of anxiety disorders with selank]human Zh Nevrol Psikhiatr Im S S Korsakova · 2015 · PMID 26356395 →
- [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]human Zh Nevrol Psikhiatr Im S S Korsakova · 2014 · PMID 25176261 →
- [Immunomodulatory effects of selank in patients with anxiety-asthenic disorders]human Zh Nevrol Psikhiatr Im S S Korsakova · 2008 · PMID 18577961 →
- Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activityreview Protein Pept Lett · 2018 · PMID 30255741 →
Educational content. It does not include doses, protocols or preparation: that is defined by a professional.